Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. badger

BADGER SIGNED

CalScreener® – an innovative device for Bacterial Analysis and Diagnostics through Growth and Energy-release in Real-time

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 BADGER project word cloud

Explore the words cloud of the BADGER project. It provides you a very rough idea of what is the project "BADGER" about.

clinicians    intend    lack    rapid    clinical    misuse    assay    combination    efficient    patients    segment    symcel    clinically    resistance    accuracy    settings    commercializing    contributes    paradigm    correct    calorimetric    inappropriate    foundation    overuse    cellular    mic    resistant    sold    daily    treatment    near    patient    commercial    readily    packaged    introduce    antimicrobial    micro    tools    lay    pure    ast    tool    antibiotic    cell    vitro    speed    badger    ill    sepsis    perform    extensively    meet    hetero    causing    broad    bioenergetics    diagnostic    susceptibility    combat    prescribing    validate    amr    setting    break    designed    provides    healthcare    calorimetry    smartly    time    validating    decisions    strains    critically    suitable    first    stewardship    isothermal    redefine    service    sensitivity    gt    date    pharmaceutical    accurate    assays    infections    line    solution    though    device    diagnoses    specificity    calscreenertm    multichannel    antibiotics    personalized    diagnostics   

Project "BADGER" data sheet

The following table provides information about the project.

Coordinator		 SYMCEL AB 

Organization address
address: DOMNARVSGATAN 4
city: SPANGA
postcode: 163 53
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Sweden [SE]
 Project website https://symcel.com/h2020-ast-combination-testing/
 Total cost 3˙572˙567 €
 EC max contribution 3˙572˙567 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2020-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYMCEL AB SE (SPANGA) coordinator 3˙572˙567.00

Map

 Project objective

SymCel provides a novel cell-based assay tool for real-time cellular bioenergetics measurements. Our key product, the calScreenerTM, is the first multichannel calorimetric system specifically developed for cell-based assays, which to date has been sold to the pharmaceutical research segment only. Even though calorimetry is a highly advanced research tool, it is considered not suitable for broad scale uptake into daily clinical practice. Through the BADGER project we intend to break this paradigm by validating and commercializing an in vitro diagnostic tool, that is based on isothermal micro calorimetry, for determining MIC for antimicrobial susceptibility testing (AST) of hetero-resistant sepsis causing strains. By providing a tool for the easy, correct and timely diagnoses of hetero-resistant and extensively resistant infections, we will redefine the commercial application segment for calorimetry systems (from pure research settings -> near patient diagnostics) and take AST to a new level of accuracy and speed. The clinical importance of AST is increasing in line with the growing concerns over antimicrobial-resistance (AMR) and the misuse of antibiotics. Lack of a rapid, low-cost and readily available solution contributes to the inappropriate prescribing and overuse of antibiotics. Clinicians are in need of an accurate and rapid diagnostic test to increase antibiotic stewardship, introduce combination treatment for critically ill patients and help combat AMR. The calScreenerTM will meet the users’ needs by providing a reliable diagnostic tool with high speed, specificity, and sensitivity in a smartly designed and packaged device with the tools available to perform testing in a near-patient setting. In all, the Phase 2 project will lay the foundation to clinically validate the calScreenerTM which will improve diagnostic decisions, provide a higher service level for patients, combat AMR and allow for more personalized and cost-efficient approaches to healthcare.

 Deliverables

List of deliverables.
Project subpage on corporate website Websites, patent fillings, videos etc. 2020-03-04 09:46:23
Ethics approval for Clinical study no. 2 Documents, reports 2020-03-04 09:46:23
Ethics approval for Clinical study no. 1 Documents, reports 2020-03-04 09:46:23
Ethics approval for Clinical study no. 3 Documents, reports 2020-03-04 09:46:23

Take a look to the deliverables list in detail:  detailed list of BADGER deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BADGER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BADGER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More